Skip to content

Video gaming as an add-on intervention in emotion regulation therapy among adolescents with internalizing disorders: a preliminary study.

Video gaming as an add-on intervention in emotion regulation therapy among adolescents with internalizing disorders: a preliminary study.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26125
Enrollment
12
Registered
2019-12-03
Start date
2019-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive or anxiety disorder and emotion regulation difficulties

Interventions

Dojo (developed by Gamedesk, Los Angeles, CA) is an 3D game for adolescents who have emotion regulation problems. In the game, emotions are being challenged and adolescents learn how to accurately cop

Sponsors

No sponsors
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adolescents are being included when there is internalizing psychopathology (a depressive or anxiety disorder is measured with the Dutch translation of the Mini International Neuropsychiatric Interview for children and adolescents (MINI-KID) and emotion regulation difficulties, which are measured with the FEEL-KJ (an instrument to measure emotion regulation strategies in children and adolescents). - Cut off score FEEL- KJ: Adaptive emotion regulation strategies 60 (high dysfunctional use of emotion regulation strategies).

Exclusion criteria

Exclusion criteria: Adolescents are excluded from the study if there is an other mental disorder diagnosed, such as ADHD, autism or substance abuse.

Design outcomes

Primary

MeasureTime frame
Satisfaction (likert scale) Duration/ fequency adolescents play the game (gamelogs)

Secondary

MeasureTime frame
Negative effects measured with the FEEL-KJ, CDI-2/YAM-5, DERS, Kidscreen-52, interview

Contacts

Public ContactLaura Knoop-Munsterman

Pro Persona

l.knoop@propersona.nl0630266065

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)